Atlas Trials

Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis

Clinical trial NCT00004762 · COMPLETED

Trial details

NCT number
NCT00004762
Sponsor
National Center for Research Resources (NCRR)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cholangitis, Sclerosing
Start date
1994-12-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.